These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1146770)

  • 1. The partial thromboplastin time in the CAP survey program.
    Koepke JA
    Am J Clin Pathol; 1975 Jun; 63(6 SUPPL):990-4. PubMed ID: 1146770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program.
    Harms CS; Triplett DA; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):560-2. PubMed ID: 707422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cap survey results for factor VIII assays (1977-1978).
    Kocoshis TA; Triplett DA
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):346-51. PubMed ID: 474513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyophilised plasmas for one-stage determination of factor VIII.
    Sikorová J; Vorlová Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):906-13. PubMed ID: 6162757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL; Triplett DA
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
    Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 8. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
    Korsan-Bengtsen K
    Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The partial thromboplastin time test: distinction between inhibitor and clotting-factor deficiency.
    Knights SF; Wadey CA
    Med Lab Technol; 1973 Jan; 30(1):43-7. PubMed ID: 4718028
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program.
    Cunningham MT; Brandt JT; Chandler WL; Eby CS; Hayes TE; Krishnan J; Lefkowitz JB; Olson JD; Stasik CJ; Teruya J; Van Cott EM
    Semin Thromb Hemost; 2007 Apr; 33(3):250-8. PubMed ID: 17427059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of partial thromboplastin time. 3].
    Yatani N; Shimoda T; Kanuma K; Genba A; Tzsukada H
    Rinsho Byori; 1971 Aug; 19():Suppl:247. PubMed ID: 5167945
    [No Abstract]   [Full Text] [Related]  

  • 16. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies on the determination of factor VIII activity].
    Moser S; Pflugshaupt R
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1372-3. PubMed ID: 4423312
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quality control of coagulation tests (author's transl)].
    Sommer R; Hohenwallner W
    Wien Klin Wochenschr; 1976 Jan; 88(1):19-25. PubMed ID: 960696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of factor VIII. A potential risk factor for vascular disease.
    Brandt JT
    Arch Pathol Lab Med; 1993 Jan; 117(1):48-51. PubMed ID: 8418762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of coagulation laboratory practice in Thailand: the first step to establish a National External Quality Assessment Scheme (NEQAS) for blood coagulation.
    Tientadakul P; Opartkiattikul N; Wongtiraporn W
    J Med Assoc Thai; 2007 Dec; 90(12):2616-23. PubMed ID: 18386711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.